

Nuclear Medicine Symposium
Radiopharmaceuticals is experiencing rapid growth nationally and is poised for greater investment and breakthroughs in patient care.
Greater Philadelphia is an emerging powerhouse for radiopharmaceutical and nuclear medicine innovation, offering one of the most diverse and connected ecosystems in the world. Anchored by world‑class clinical and research institutions across Pennsylvania, New Jersey, and Delaware, the region supports seamless translation from discovery to commercialization. The region’s integrated academic, clinical, and industry network provides a foundation for scaling innovation and shaping national strategy.
To strengthen this momentum, we are including a national list of key academic and industry participants to map the landscape, identify collaboration opportunities, and accelerate progress across the field.
KEYNOTE: To be Announced
PANELISTS for Industry Fireside Chat:
Jon Epstein, Dean of Penn Perelman School of Medicine
Jeff Marrazzo, Founder of Spark Therapeutics and Chairman, Dispatch Bio
Steve Hahn, Chairman and CEO of Nucleus Radiopharmaceuticals (and former FDA Commissioner)
Mark Mintun, Group VP of Lilly Neuroscience R&D and President of Avid Radiopharmaceuticals
Cocktail Reception to Follow